Insulet Q2 ’19 Earnings Update
Insulet hosted its Q2 ’19 earnings call and provided updates to its commercial and pipeline activities including the Omnipod Horizon hybrid closed-loop development. Below are highlights and insights from the call.
Insulet hosted its Q2 ’19 earnings call and provided updates to its commercial and pipeline activities including the Omnipod Horizon hybrid closed-loop development. Below are highlights and insights from the call.
JDRF, ADA, and the Helmsley charitable trust awarded a grant for a study evaluating the variability of insulin potency in US pharmacies. Additionally, Tidepool recently announced a program to support the DIY Loop automated insulin-delivery project through an FDA-regulated manner. Below, FENIX provides a brief overview and thoughts on each new project, including Tidepool’s potential motivation.